Search PubMed⌕ Search

Biomedical subjects

E Macotela-Ruiz

Publications and source records attributed to E Macotela-Ruiz.

13 recordsLinked to original sources
PubMed1988

[Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].

In a double-blind test it was shown the efficacy of topical fusidic acid in comparison with oral dicloxacillin, in patients with skin infection by Staphylococcus aureus or/and Streptococcus pyogenes. In the experimental group, 16 patients from 20 received 2% topical fusidic acid in cream and reacted well in a shorter period of time than 17 from a group of 20 that had 500 mg. of dicloxacillin orally twice a day.

Administration, Oral↗
PubMed1977

[Tinea].

Explore the source record for details and available documents.

Antifungal Agents↗
PubMedDate not supplied

[Sarcoidosis (intra- and extrathoracic): apropos a Mexican case].

In this paper, we report a case of sarcoidosis, in a 15-years-old boy. Clinical picture has cutaneous findings as only manifestation. Clinical approach was oriented by reticulosis. Diagnosis of sarcoidosis, was based in scans that shows pulmonary involvement. Lastly, granulomatoses disorders most common in our country, like tuberculosis and leprosy, were excluded.

Adolescent↗
PubMedDate not supplied

[Cutaneous leukocytoclastic vasculitis as a marker of systemic diseases].

Fifty-eight patients with cutaneous leukocytoclastic vasculitis were evaluated. The most frequent cutaneous manifestation was purpura, followed by palpable purpura. Vascular inflammation was confirmed by skin biopsy: two distinct patterns of cellular infiltrate were found, a neutrophilic-predominant and a mononuclear-predominant type, as a manifestation of the dynamic evolution of the process. On the basis of the associated disease we grouped our cases as follows: autoimmune disease, reaction, malignancy, infection and idiopathic.

Adolescent↗
PubMedDate not supplied

[The importance of the protein antigens of Mycobacterium leprae. Their potential use for the development of a vaccine against leprosy].

The purpose of this review is to describe M. leprae antigenic structures that are considered relevant for the development of a vaccine. Other biological elements presently utilized in vaccination and immune therapy against leprosy are also reviewed, and the possibility of having in the future an effective vaccine obtained at low cost through molecular biology recombinant techniques. This review also describes some epidemiological and control aspects of leprosy within the general framework of the importance of this disease.

Antigens, Bacterial↗